Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6780503 | 0.72 | — | — | |
| SCHEMBL301586 | 0.67 | ALDH1A1 (0.36) | TDP1TSHRALDH1A1 | |
| SCHEMBL6242458 | 0.65 | TSHR (0.44) | TDP1TSHR | |
| SCHEMBL18857032 | 0.64 | ALDH1A1 (0.33) | TDP1TSHRALDH1A1 | |
| SCHEMBL14438559 | 0.64 | — | — | |
| SCHEMBL11301061 | 0.64 | ALDH1A1 (0.33) | TDP1TSHRALDH1A1 | |
| SCHEMBL9614550 | 0.62 | — | — | |
| SCHEMBL3729759 | 0.61 | TSHR (0.31) | TDP1TSHRALDH1A1 | |
| SCHEMBL211658 | 0.61 | ALDH1A1 (0.38) | TDP1TSHRALDH1A1 | |
| SCHEMBL2216329 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116283923-A | Preparation method of biaryl compound | 杭州师范大学 | 2023-06-23 | — | — | CN | claimed |
| CN-112745350-B | Synthesis method of 4-alkyl phosphonate substituted indole compound | 山东领海生物科技有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-118355020-A | Therapeutic compounds for HIV virus infection | 吉利德科学公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-116283923-A | Preparation method of biaryl compound | 杭州师范大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-113801254-B | Polypropylene catalyst and preparation method thereof | 中国石油天然气股份有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-112745350-B | Synthesis method of 4-alkyl phosphonate substituted indole compound | 山东领海生物科技有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-112745350-B | Synthesis method of 4-alkyl phosphonate substituted indole compound | 山东领海生物科技有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-113801254-A | Polypropylene catalyst and preparation method thereof | 中国石油天然气股份有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-112745350-A | Synthesis method of 4-alkyl phosphonate substituted indole compound | 山东领海生物科技有限公司 | 2021-05-04 | — | — | CN | disclosed |
| US-8445695-B2 | Synthesis of phosphono-substituted porphyrin compounds for attachment to metal oxide surfaces | NORTH CAROLINA STATE UNIVERSITY (US) | 2013-05-21 | — | — | US | disclosed |
| US-20120322999-A1 | Synthesis of Phosphono-Substituted Porphyrin Compounds for Attachment to Metal Oxide Surfaces | LINDSEY JONATHAN S (US) | 2012-12-20 | — | — | US | disclosed |
| US-6825191-B2 | ANTICOAGULANT | AJINOMOTO CO., INC. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-20030186969-A1 | Benzodiazepine derivatives | AJINOMOTO CO. INC (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1329450-A1 | BENZODIAZEPINE DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2003-07-23 | — | — | EP | disclosed |
| EP-1242432-A1 | PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B (PTP-1B) | MERCK FROSST CANADA INC. (CA) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001046205-A1 | PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B (PTP-1B) | MERCK FROSST CANADA & CO. (CA) | 2001-06-28 | — | — | WO | disclosed |
| EP-0987253-A1 | PYRAZOLONE DERIVATIVES | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 2000-03-22 | — | — | EP | disclosed |
| US-5968967-A | INHIBIT PLATELET AGGREGATION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1999-10-19 | — | — | US | disclosed |
| EP-0765160-A4 | — | — | 1997-04-09 | — | — | EP | disclosed |
| EP-0765160-A1 | DEXANABINOL DERIVATIVES AND THEIR USE AS NEUROPROTECTIVE PHARMACEUTICAL COMPOSITIONS | RAMOT UNIVERSITY, AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) | 1997-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030186969-A1 | Benzodiazepine derivatives | GABRA1, F11, GABRA4 | TDP1 2357/4885TSHR 679/4885ALDH1A1 633/4885 |
| US-20120322999-A1 | Synthesis of Phosphono-Substituted Porphyrin Compounds for Attachment to Metal Oxide Surfaces | PPOX, DAO, DDO | TDP1 2456/4885TSHR 4020/4885ALDH1A1 1570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.